Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00530023 · ClinicalTrials.gov registry record · Phase 4
Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness
A Phase 4 study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- Phase 4
- Development phase
- 29
- Enrollment target
NCT00530023: Completed Phase 4 study, sponsored by Medtronic MiniMed.
NCT00530023 is a Phase 4 study that has completed, run by Medtronic MiniMed. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00530023, a Phase 4 study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 29 participants
- Enrollment target
Study Summary
Feasibility study to compare the effectiveness of the Paradigm Sensor Augmented System versus subjects continuing to administer insulin in multiple dose injections. Evaluate the educational materials and time required for training subjects naïve to continuous subcutaneous insulin infusion (CSII) to use the Paradigm 722 REAL Time System in preparation for a large multi-center clinical trial
Interventions
- DEVICE MiniMed Paradigm REAL-Time System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2006-02 |
| Est. Completion | 2006-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00530023
The ClinicalTrials.gov registry entry for NCT00530023 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MiniMed Paradigm REAL-Time System is the first listed.
NCT00530023 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00530023 about?
NCT00530023 is a clinical study titled "Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness". Feasibility study to compare the effectiveness of the Paradigm Sensor Augmented System versus subjects continuing to administer insulin in multiple dose injections. Evaluate the educational materials and time required for training subjects naïve to continuous subcutaneous insulin infusion (CSII) to ...
What is the current status of trial NCT00530023?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 29 participants. The study started on 2006-02. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00530023?
The interventions under investigation include: MiniMed Paradigm REAL-Time System (DEVICE).
Who is sponsoring clinical trial NCT00530023?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.